- Home
- CLLS vs MLAB Comparison
CLLS vs MLAB Comparison
Compare CLLS & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | MLAB |
|---|---|---|
| Founded | 1999 | 1982 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.3M | 442.0M |
| IPO Year | 2014 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CLLS | MLAB |
|---|---|---|
| Price | $3.24 | $83.48 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | $8.50 | ★ $94.00 |
| AVG Volume (30 Days) | 48.3K | ★ 114.7K |
| Earning Date | 03-19-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 0.79% |
| EPS Growth | N/A | ★ 99.24 |
| EPS | N/A | ★ 1.95 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.07 |
| Revenue Next Year | N/A | $5.41 |
| P/E Ratio | ★ N/A | $41.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.10 | $59.63 |
| 52 Week High | $5.48 | $128.55 |
Technical Indicators
Market Signals| Indicator | CLLS | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 48.17 |
| Support Level | $3.32 | $69.73 |
| Resistance Level | $3.83 | $89.69 |
| Average True Range (ATR) | 0.21 | 3.82 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 22.37 | 70.85 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.